Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

5.21
Delayed Data
As of Aug 23
 -0.20 / -3.70%
Today’s Change
2.85
Today|||52-Week Range
7.58
-3.52%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close5.41
Today’s open5.41
Day’s range5.15 - 5.47
Volume346,914
Average volume (3 months)421,026
Market cap$163.1M
Dividend yield--
Data as of 08/23/2016

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-27.86%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book3.30

Competitors

 Today’s
change
Today’s
% change
CCMConcord Medical Serv...-0.07-1.60%
PMDPsychemedics Corp+0.11+0.52%
CPHRCipher Pharmaceutica...-0.05-1.20%
CDNACareDx Inc+0.03+0.65%
Data as of 08/23/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William J. Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs